These findings suggest that the pathological processes of cardiomyopathy are influenced by RPL3l through multiple mechanisms, including inflammatory regulation, mitochondria-ribosome interactions, and translational control, providing new insights into the pathogenesis of DCM and potential therapeutic strategies. This evidence concerns the gene RPL3L and cardiomyopathy.